Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Akums Drugs and Pharmaceuticals has informed the stock exchanges that the trading window for its securities will be closed for all designated persons and their immediate relatives starting April 1, 2026. The window will remain shut until 48 hours after the company declares its audited financial results for the quarter and full year ending March 31, 2026. This is a routine compliance measure under SEBI's Insider Trading Regulations, 2015, typically enforced ahead of earnings announcements. The exact date of the board meeting to approve these results has not yet been disclosed and will be communicated later.
This is a standard regulatory filing with no direct impact on shareholders. Designated insiders cannot trade during this period, and the upcoming results announcement (once made) could influence the stock price depending on the numbers reported.